Back to Search
Start Over
Johnson & Johnson announces results from Phase 3 CARTITUDE-4 study
- Source :
- The Fly. July 2, 2024
- Publication Year :
- 2024
-
Abstract
- Johnson & Johnson announced positive results from a prespecified second interim analysis of the Phase 3 CARTITUDE-4 study evaluating CARVYKTI compared to standard therapies of pomalidomide, bortezomib and dexamethasone or [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.799826528